Bioxytran, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-619.9K | $-2.1M | $-522.2K | $-282.7K | $35.4K | $-1.4M | $-752.1K | $-392.4K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $5.6K | $2.1K | $2.9K | $4.2K | $2.5K | $1.9K | $2.9K | $1.5K |
| Stock-Based Compensation | — | — | — | — | — | — | — | $8.4K |
| Net Cash from Operating Activities | $-349.8K | $-238.6K | $-237.0K | $-49.0K | $-73.2K | $-167.3K | $-127.9K | $-73.5K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-9.4K | $-9.2K | $-6.2K | $-4.2K | $-12.7K | $-15 | $-12.1K | $-10.8K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $73.5K | $201.0K | $738.6K | $64.5K | $84.6K | $166.5K | $110.5K | $105.5K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |